Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Matrix metalloproteinases as therapeutic targets in breast cancer. | Front Oncol | 2022 | 36741729 | PubTator, text mining | PubMed |
| Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq. | Cancer Drug Resist | 2022 | 36627902 | PubTator, text mining | PubMed |
| Resolution Potential of Necrotic Cell Death Pathways. | Int J Mol Sci | 2022 | 36613458 | PubTator, text mining | PubMed |
| The Role of CXC Chemokines in Cancer Progression. | Cancers (Basel) | 2022 | 36612163 | PubTator, text mining | PubMed |
| IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals. | Front Psychiatry | 2022 | 36590607 | PubTator, text mining | PubMed |
| Signaling pathways of adipose stem cell-derived exosomes promoting muscle regeneration. | Chin Med J (Engl) | 2022 | 36583914 | PubTator, text mining | PubMed |
| Horizon scan: State-of-the-art therapeutics for psoriatic arthritis. | Best Pract Res Clin Rheumatol | 2022 | 36567224 | PubTator, text mining | PubMed |
| Polymeric Nanoparticles for Drug Delivery in Osteoarthritis. | Pharmaceutics | 2022 | 36559133 | PubTator, text mining | PubMed |
| MK2 Inhibitors as a Potential Crohn's Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity. | Pharmaceuticals (Basel) | 2022 | 36558958 | PubTator, text mining | PubMed |
| Association of Inherited Copy Number Variation in ADAM3A and ADAM5 Pseudogenes with Oropharynx Cancer Risk and Outcome. | Genes (Basel) | 2022 | 36553675 | PubTator, text mining | PubMed |
| An Approach for Systems-Level Understanding of Prostate Cancer from High-Throughput Data Integration to Pathway Modeling and Simulation. | Cells | 2022 | 36552885 | PubTator, text mining | PubMed |
| Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. | Cells | 2022 | 36552831 | PubTator, text mining | PubMed |
| Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids. | Front Immunol | 2022 | 36544778 | PubTator, text mining | PubMed |
| Editor's Note: p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity. | Cancer Res | 2022 | 36524348 | PubTator, text mining | PubMed |
| MicroRNAs: a crossroad that connects obesity to immunity and aging. | Immun Ageing | 2022 | 36517853 | PubTator, text mining | PubMed |
| Modular Peroxidase-Based Reporters for Detecting Protease Activity and Protein Interactions with Temporal Gating. | J Am Chem Soc | 2022 | 36511757 | PubTator, text mining | PubMed |
| Neutrophil Immunomodulatory Activity of Nerolidol, a Major Component of Essential Oils from Populus balsamifera Buds and Propolis. | Plants (Basel) | 2022 | 36501438 | PubTator, text mining | PubMed |
| ATR Inhibitors in Platinum-Resistant Ovarian Cancer. | Cancers (Basel) | 2022 | 36497387 | PubTator, text mining | PubMed |
| Modern vision of the Mediterranean diet. | J Prev Med Hyg | 2022 | 36479477 | PubTator, text mining | PubMed |
| Revealing oxidative stress-related genes in osteoporosis and advanced structural biological study for novel natural material discovery regarding MAPKAPK2. | Front Endocrinol (Lausanne) | 2022 | 36479222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=20